Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ats Corp (ATS.TO)

Ats Corp (ATS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,448,375
  • Shares Outstanding, K 98,220
  • Annual Sales, $ 2,577 M
  • Annual Income, $ 127,433 K
  • 60-Month Beta 1.57
  • Price/Sales 1.46
  • Price/Cash Flow 43.70
  • Price/Book 2.84
Trade ATS.TO with:

Options Overview Details

View History
  • Implied Volatility 36.60% ( +1.18%)
  • Historical Volatility 33.88%
  • IV Percentile 94%
  • IV Rank 86.21%
  • IV High 39.26% on 10/31/23
  • IV Low 20.01% on 02/09/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 595
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 19,596
  • Open Int (30-Day) 11,275

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.55
  • Number of Estimates 4
  • High Estimate 0.58
  • Low Estimate 0.49
  • Prior Year 0.73
  • Growth Rate Est. (year over year) -24.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.12 +7.73%
on 04/17/24
46.18 -4.07%
on 04/03/24
-1.42 (-3.11%)
since 04/01/24
3-Month
41.12 +7.73%
on 04/17/24
59.46 -25.50%
on 02/06/24
-14.38 (-24.51%)
since 02/01/24
52-Week
41.12 +7.73%
on 04/17/24
64.80 -31.64%
on 07/19/23
-14.95 (-25.23%)
since 05/01/23

Most Recent Stories

More News
Stocks in play: ATS Corporation

Will report its financial results for the fourth quarter ended March 31, 2024, before markets open on ...

ATS.TO : 44.30 (-2.19%)
Stocks in play: ATS Corporation

Announced that Andrew Hider, Chief Executive Officer and Ryan McLeod, Chief Financial Officer will participate ...

ATS.TO : 44.30 (-2.19%)
Stocks in play: ATS Corporation

Today reported its financial results for the three months ended December 31, 2023. Third-quarter highlights: ...

ATS.TO : 44.30 (-2.19%)
Stocks in play: ATS Corporation

Announced that Andrew Hider, Chief Executive Officer and Ryan McLeod, Chief Financial Officer will participate ...

ATS.TO : 44.30 (-2.19%)
Stocks in play: ATS Corporation

Today reported its financial results for the three months ended October 1, 2023. Revenues increased ...

ATS.TO : 44.30 (-2.19%)
ATS To Host Second Quarter Earnings Call Wednesday November 8, 2023, at 8:30 a.m. Eastern

/CNW/ - ATS Corporation (TSX: ATS) (NYSE: ATS) ("ATS" or the "Company") will report its financial results for the second quarter ended October 1, 2023, before...

ATS : 32.18 (-2.19%)
ATS.TO : 44.30 (-2.19%)
ATS signs deal to buy water purification company Avidity Science for $265 million

CAMBRIDGE, Ont. — ATS Corp. has signed a deal to buy Avidity Science LLC, a designer and manufacturer of automated water purification solutions for biomedical and life science applications, for $265...

ATS.TO : 44.30 (-2.19%)
ATS To Acquire Biomedical Research & Life Sciences Water Purification Equipment Provider Avidity Science

/CNW/ - ATS Corporation (TSX: ATS) (NYSE: ATS) ("ATS" or the "Company") a leading automation solutions provider, today announced it has entered into a...

ATS : 32.18 (-2.19%)
ATS.TO : 44.30 (-2.19%)
ATS To Acquire Biomedical Research & Life Sciences Water Purification Equipment Provider Avidity Science

/PRNewswire/ - ATS Corporation (TSX: ATS) (NYSE: ATS) ("ATS" or the "Company") a leading automation solutions provider, today announced it has entered into a...

ATS.TO : 44.30 (-2.19%)
ATS : 32.18 (-2.19%)
ATS Hosts 2023 Institutional Investor Day

/PRNewswire/ - ATS Corporation (TSX: ATS) (NYSE: ATS) ("ATS" or the "Company"), an industry-leading automation solutions provider, is sharing additional...

ATS.TO : 44.30 (-2.19%)
ATS : 32.18 (-2.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails,...

See More

Key Turning Points

3rd Resistance Point 46.13
2nd Resistance Point 45.68
1st Resistance Point 44.99
Last Price 44.30
1st Support Level 43.85
2nd Support Level 43.40
3rd Support Level 42.71

See More

52-Week High 64.80
Fibonacci 61.8% 55.75
Fibonacci 50% 52.96
Fibonacci 38.2% 50.17
Last Price 44.30
52-Week Low 41.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar